• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.

出版信息

PLoS One. 2019 Sep 10;14(9):e0222507. doi: 10.1371/journal.pone.0222507. eCollection 2019.

DOI:10.1371/journal.pone.0222507
PMID:31504076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6736284/
Abstract
摘要

相似文献

1
Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.撤回声明：肝细胞癌肝移植患者三种不同免疫抑制方案的综合比较：无类固醇免疫抑制、诱导免疫抑制和标准免疫抑制。
PLoS One. 2019 Sep 10;14(9):e0222507. doi: 10.1371/journal.pone.0222507. eCollection 2019.
2
Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.三种不同免疫抑制方案用于肝细胞癌肝移植患者的综合比较：无类固醇免疫抑制、诱导免疫抑制和标准免疫抑制。
PLoS One. 2015 Mar 27;10(3):e0120939. doi: 10.1371/journal.pone.0120939. eCollection 2015.
3
Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.撤稿声明：肝细胞癌肝移植患者无类固醇免疫抑制与标准免疫抑制的比较
PLoS One. 2019 Sep 4;14(9):e0222257. doi: 10.1371/journal.pone.0222257. eCollection 2019.
4
Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression.识别肝移植候选者的风险特征及其对诱导免疫抑制的影响。
Transplant Rev (Orlando). 2018 Jul;32(3):142-150. doi: 10.1016/j.trre.2018.04.001. Epub 2018 Apr 13.
5
Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌肝移植术后无类固醇免疫抑制方案的疗效与安全性
Gut Liver. 2016 Jul 15;10(4):604-10. doi: 10.5009/gnl15017.
6
Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.接受无类固醇维持免疫抑制治疗的原发性肾移植受者的临床效果良好。
Clin Transplant. 2006 Sep-Oct;20(5):537-46. doi: 10.1111/j.1399-0012.2006.00521.x.
7
Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.肝移植后复发风险高的肝细胞癌患者基于依维莫司的免疫抑制：病例系列
Transplant Proc. 2014 Dec;46(10):3496-501. doi: 10.1016/j.transproceed.2014.08.045.
8
Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.胰腺移植受者使用雷帕霉素和低剂量新山地明进行无类固醇维持免疫抑制治疗。
Transplantation. 2007 Nov 15;84(9):1131-7. doi: 10.1097/01.tp.0000287117.98785.54.
9
Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.在 1000 例长期随访的肝移植患者中，使用兔抗胸腺细胞球蛋白联合或不联合利妥昔单抗进行免疫抑制诱导。
Liver Transpl. 2012 Jul;18(7):786-95. doi: 10.1002/lt.23381.
10
New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.肾移植受者在无类固醇免疫抑制治疗出院后新发糖尿病。
Transplantation. 2011 Feb 15;91(3):334-41. doi: 10.1097/TP.0b013e318203c25f.

本文引用的文献

1
Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.中国涉及器官移植的同行评审出版物中报告供体来源和伦理审查的道德标准遵循情况：范围综述。
BMJ Open. 2019 Feb 5;9(2):e024473. doi: 10.1136/bmjopen-2018-024473.
2
Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.三种不同免疫抑制方案用于肝细胞癌肝移植患者的综合比较：无类固醇免疫抑制、诱导免疫抑制和标准免疫抑制。
PLoS One. 2015 Mar 27;10(3):e0120939. doi: 10.1371/journal.pone.0120939. eCollection 2015.